ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Monovalent Antivenom Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-23R6342
Home | Market Reports | Health| Pharmacy
Global Monovalent Antivenom Market Insights Forecast to 2028
BUY CHAPTERS

Global Monovalent Antivenom Market Research Report 2025

Code: QYRE-Auto-23R6342
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Limited
Merck
BTG Plc
Pfizer Inc
Haffkine Bio Pharmaceutical
Vins Bioproducts
Serum Biotech

Monovalent Antivenom Market Size

The global market for Monovalent Antivenom was valued at US$ 409 million in the year 2024 and is projected to reach a revised size of US$ 505 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Monovalent Antivenom Market

Monovalent Antivenom Market

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Monovalent Antivenom, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monovalent Antivenom.
The Monovalent Antivenom market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monovalent Antivenom market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monovalent Antivenom manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Monovalent Antivenom Market Report

Report Metric Details
Report Name Monovalent Antivenom Market
Accounted market size in year US$ 409 million
Forecasted market size in 2031 US$ 505 million
CAGR 3.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Non-profit Institutions
  • Hospitals and Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Vins Bioproducts, Serum Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Monovalent Antivenom manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Monovalent Antivenom in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Monovalent Antivenom Market growing?

Ans: The Monovalent Antivenom Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Monovalent Antivenom Market size in 2031?

Ans: The Monovalent Antivenom Market size in 2031 will be US$ 505 million.

Who are the main players in the Monovalent Antivenom Market report?

Ans: The main players in the Monovalent Antivenom Market are CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Vins Bioproducts, Serum Biotech

What are the Application segmentation covered in the Monovalent Antivenom Market report?

Ans: The Applications covered in the Monovalent Antivenom Market report are Non-profit Institutions, Hospitals and Clinic

What are the Type segmentation covered in the Monovalent Antivenom Market report?

Ans: The Types covered in the Monovalent Antivenom Market report are Coral Snakes Antivenom, Sea Snakes Antivenom, Brown Snake Antivenom, Others

Recommended Reports

Antivenom & Immunoglobulins

Antibody Research

Injection & Coagulation

1 Monovalent Antivenom Market Overview
1.1 Product Definition
1.2 Monovalent Antivenom by Type
1.2.1 Global Monovalent Antivenom Market Value Comparison by Type (2024 VS 2031)
1.2.2 Coral Snakes Antivenom
1.2.3 Sea Snakes Antivenom
1.2.4 Brown Snake Antivenom
1.2.5 Others
1.3 Monovalent Antivenom by Application
1.3.1 Global Monovalent Antivenom Market Value by Application (2024 VS 2031)
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Global Monovalent Antivenom Market Size Estimates and Forecasts
1.4.1 Global Monovalent Antivenom Revenue 2020-2031
1.4.2 Global Monovalent Antivenom Sales 2020-2031
1.4.3 Global Monovalent Antivenom Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Monovalent Antivenom Market Competition by Manufacturers
2.1 Global Monovalent Antivenom Sales Market Share by Manufacturers (2020-2025)
2.2 Global Monovalent Antivenom Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Monovalent Antivenom Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Monovalent Antivenom, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Monovalent Antivenom, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Monovalent Antivenom, Product Type & Application
2.7 Global Key Manufacturers of Monovalent Antivenom, Date of Enter into This Industry
2.8 Global Monovalent Antivenom Market Competitive Situation and Trends
2.8.1 Global Monovalent Antivenom Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Monovalent Antivenom Players Market Share by Revenue
2.8.3 Global Monovalent Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Monovalent Antivenom Market Scenario by Region
3.1 Global Monovalent Antivenom Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Monovalent Antivenom Sales by Region: 2020-2031
3.2.1 Global Monovalent Antivenom Sales by Region: 2020-2025
3.2.2 Global Monovalent Antivenom Sales by Region: 2026-2031
3.3 Global Monovalent Antivenom Revenue by Region: 2020-2031
3.3.1 Global Monovalent Antivenom Revenue by Region: 2020-2025
3.3.2 Global Monovalent Antivenom Revenue by Region: 2026-2031
3.4 North America Monovalent Antivenom Market Facts & Figures by Country
3.4.1 North America Monovalent Antivenom Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Monovalent Antivenom Sales by Country (2020-2031)
3.4.3 North America Monovalent Antivenom Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Monovalent Antivenom Market Facts & Figures by Country
3.5.1 Europe Monovalent Antivenom Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Monovalent Antivenom Sales by Country (2020-2031)
3.5.3 Europe Monovalent Antivenom Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Monovalent Antivenom Market Facts & Figures by Region
3.6.1 Asia Pacific Monovalent Antivenom Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Monovalent Antivenom Sales by Region (2020-2031)
3.6.3 Asia Pacific Monovalent Antivenom Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Monovalent Antivenom Market Facts & Figures by Country
3.7.1 Latin America Monovalent Antivenom Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Monovalent Antivenom Sales by Country (2020-2031)
3.7.3 Latin America Monovalent Antivenom Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Monovalent Antivenom Market Facts & Figures by Country
3.8.1 Middle East and Africa Monovalent Antivenom Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Monovalent Antivenom Sales by Country (2020-2031)
3.8.3 Middle East and Africa Monovalent Antivenom Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Monovalent Antivenom Sales by Type (2020-2031)
4.1.1 Global Monovalent Antivenom Sales by Type (2020-2025)
4.1.2 Global Monovalent Antivenom Sales by Type (2026-2031)
4.1.3 Global Monovalent Antivenom Sales Market Share by Type (2020-2031)
4.2 Global Monovalent Antivenom Revenue by Type (2020-2031)
4.2.1 Global Monovalent Antivenom Revenue by Type (2020-2025)
4.2.2 Global Monovalent Antivenom Revenue by Type (2026-2031)
4.2.3 Global Monovalent Antivenom Revenue Market Share by Type (2020-2031)
4.3 Global Monovalent Antivenom Price by Type (2020-2031)
5 Segment by Application
5.1 Global Monovalent Antivenom Sales by Application (2020-2031)
5.1.1 Global Monovalent Antivenom Sales by Application (2020-2025)
5.1.2 Global Monovalent Antivenom Sales by Application (2026-2031)
5.1.3 Global Monovalent Antivenom Sales Market Share by Application (2020-2031)
5.2 Global Monovalent Antivenom Revenue by Application (2020-2031)
5.2.1 Global Monovalent Antivenom Revenue by Application (2020-2025)
5.2.2 Global Monovalent Antivenom Revenue by Application (2026-2031)
5.2.3 Global Monovalent Antivenom Revenue Market Share by Application (2020-2031)
5.3 Global Monovalent Antivenom Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Company Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Monovalent Antivenom Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Monovalent Antivenom Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Monovalent Antivenom Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Monovalent Antivenom Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 BTG
6.3.1 BTG Company Information
6.3.2 BTG Description and Business Overview
6.3.3 BTG Monovalent Antivenom Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BTG Monovalent Antivenom Product Portfolio
6.3.5 BTG Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Monovalent Antivenom Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Monovalent Antivenom Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Company Information
6.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
6.5.3 Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Haffkine Bio-Pharmaceutical Monovalent Antivenom Product Portfolio
6.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
6.6 Vins Bioproducts
6.6.1 Vins Bioproducts Company Information
6.6.2 Vins Bioproducts Description and Business Overview
6.6.3 Vins Bioproducts Monovalent Antivenom Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Vins Bioproducts Monovalent Antivenom Product Portfolio
6.6.5 Vins Bioproducts Recent Developments/Updates
6.7 Serum Biotech
6.7.1 Serum Biotech Company Information
6.7.2 Serum Biotech Description and Business Overview
6.7.3 Serum Biotech Monovalent Antivenom Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Serum Biotech Monovalent Antivenom Product Portfolio
6.7.5 Serum Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Monovalent Antivenom Industry Chain Analysis
7.2 Monovalent Antivenom Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Monovalent Antivenom Production Mode & Process Analysis
7.4 Monovalent Antivenom Sales and Marketing
7.4.1 Monovalent Antivenom Sales Channels
7.4.2 Monovalent Antivenom Distributors
7.5 Monovalent Antivenom Customer Analysis
8 Monovalent Antivenom Market Dynamics
8.1 Monovalent Antivenom Industry Trends
8.2 Monovalent Antivenom Market Drivers
8.3 Monovalent Antivenom Market Challenges
8.4 Monovalent Antivenom Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL Limited
Merck
BTG Plc
Pfizer Inc
Haffkine Bio Pharmaceutical
Vins Bioproducts
Serum Biotech
List of Tables
 Table 1. Global Monovalent Antivenom Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Monovalent Antivenom Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Monovalent Antivenom Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Monovalent Antivenom Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Monovalent Antivenom Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Monovalent Antivenom Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Monovalent Antivenom Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Monovalent Antivenom Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Monovalent Antivenom, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Monovalent Antivenom, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Monovalent Antivenom, Product Type & Application
 Table 12. Global Key Manufacturers of Monovalent Antivenom, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Monovalent Antivenom by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monovalent Antivenom as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Monovalent Antivenom Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Monovalent Antivenom Sales by Region (2020-2025) & (K Units)
 Table 18. Global Monovalent Antivenom Sales Market Share by Region (2020-2025)
 Table 19. Global Monovalent Antivenom Sales by Region (2026-2031) & (K Units)
 Table 20. Global Monovalent Antivenom Sales Market Share by Region (2026-2031)
 Table 21. Global Monovalent Antivenom Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Monovalent Antivenom Revenue Market Share by Region (2020-2025)
 Table 23. Global Monovalent Antivenom Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Monovalent Antivenom Revenue Market Share by Region (2026-2031)
 Table 25. North America Monovalent Antivenom Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Monovalent Antivenom Sales by Country (2020-2025) & (K Units)
 Table 27. North America Monovalent Antivenom Sales by Country (2026-2031) & (K Units)
 Table 28. North America Monovalent Antivenom Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Monovalent Antivenom Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Monovalent Antivenom Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Monovalent Antivenom Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Monovalent Antivenom Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Monovalent Antivenom Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Monovalent Antivenom Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Monovalent Antivenom Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Monovalent Antivenom Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Monovalent Antivenom Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Monovalent Antivenom Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Monovalent Antivenom Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Monovalent Antivenom Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Monovalent Antivenom Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Monovalent Antivenom Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Monovalent Antivenom Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Monovalent Antivenom Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Monovalent Antivenom Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Monovalent Antivenom Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Monovalent Antivenom Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Monovalent Antivenom Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Monovalent Antivenom Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Monovalent Antivenom Sales (K Units) by Type (2020-2025)
 Table 51. Global Monovalent Antivenom Sales (K Units) by Type (2026-2031)
 Table 52. Global Monovalent Antivenom Sales Market Share by Type (2020-2025)
 Table 53. Global Monovalent Antivenom Sales Market Share by Type (2026-2031)
 Table 54. Global Monovalent Antivenom Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Monovalent Antivenom Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Monovalent Antivenom Revenue Market Share by Type (2020-2025)
 Table 57. Global Monovalent Antivenom Revenue Market Share by Type (2026-2031)
 Table 58. Global Monovalent Antivenom Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Monovalent Antivenom Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Monovalent Antivenom Sales (K Units) by Application (2020-2025)
 Table 61. Global Monovalent Antivenom Sales (K Units) by Application (2026-2031)
 Table 62. Global Monovalent Antivenom Sales Market Share by Application (2020-2025)
 Table 63. Global Monovalent Antivenom Sales Market Share by Application (2026-2031)
 Table 64. Global Monovalent Antivenom Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Monovalent Antivenom Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Monovalent Antivenom Revenue Market Share by Application (2020-2025)
 Table 67. Global Monovalent Antivenom Revenue Market Share by Application (2026-2031)
 Table 68. Global Monovalent Antivenom Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Monovalent Antivenom Price (US$/Unit) by Application (2026-2031)
 Table 70. CSL Company Information
 Table 71. CSL Description and Business Overview
 Table 72. CSL Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. CSL Monovalent Antivenom Product
 Table 74. CSL Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Monovalent Antivenom Product
 Table 79. Merck Recent Developments/Updates
 Table 80. BTG Company Information
 Table 81. BTG Description and Business Overview
 Table 82. BTG Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BTG Monovalent Antivenom Product
 Table 84. BTG Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pfizer Monovalent Antivenom Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Haffkine Bio-Pharmaceutical Company Information
 Table 91. Haffkine Bio-Pharmaceutical Description and Business Overview
 Table 92. Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Haffkine Bio-Pharmaceutical Monovalent Antivenom Product
 Table 94. Haffkine Bio-Pharmaceutical Recent Developments/Updates
 Table 95. Vins Bioproducts Company Information
 Table 96. Vins Bioproducts Description and Business Overview
 Table 97. Vins Bioproducts Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Vins Bioproducts Monovalent Antivenom Product
 Table 99. Vins Bioproducts Recent Developments/Updates
 Table 100. Serum Biotech Company Information
 Table 101. Serum Biotech Description and Business Overview
 Table 102. Serum Biotech Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Serum Biotech Monovalent Antivenom Product
 Table 104. Serum Biotech Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Monovalent Antivenom Distributors List
 Table 108. Monovalent Antivenom Customers List
 Table 109. Monovalent Antivenom Market Trends
 Table 110. Monovalent Antivenom Market Drivers
 Table 111. Monovalent Antivenom Market Challenges
 Table 112. Monovalent Antivenom Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Monovalent Antivenom
 Figure 2. Global Monovalent Antivenom Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Monovalent Antivenom Market Share by Type: 2024 & 2031
 Figure 4. Coral Snakes Antivenom Product Picture
 Figure 5. Sea Snakes Antivenom Product Picture
 Figure 6. Brown Snake Antivenom Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Monovalent Antivenom Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Monovalent Antivenom Market Share by Application: 2024 & 2031
 Figure 10. Non-profit Institutions
 Figure 11. Hospitals and Clinic
 Figure 12. Global Monovalent Antivenom Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Monovalent Antivenom Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Monovalent Antivenom Sales (2020-2031) & (K Units)
 Figure 15. Global Monovalent Antivenom Average Price (US$/Unit) & (2020-2031)
 Figure 16. Monovalent Antivenom Report Years Considered
 Figure 17. Monovalent Antivenom Sales Share by Manufacturers in 2024
 Figure 18. Global Monovalent Antivenom Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Monovalent Antivenom Players: Market Share by Revenue in Monovalent Antivenom in 2024
 Figure 20. Monovalent Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Monovalent Antivenom Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Monovalent Antivenom Sales Market Share by Country (2020-2031)
 Figure 23. North America Monovalent Antivenom Revenue Market Share by Country (2020-2031)
 Figure 24. United States Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Monovalent Antivenom Sales Market Share by Country (2020-2031)
 Figure 27. Europe Monovalent Antivenom Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Monovalent Antivenom Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Monovalent Antivenom Revenue Market Share by Region (2020-2031)
 Figure 35. China Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Monovalent Antivenom Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Monovalent Antivenom Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Monovalent Antivenom Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Monovalent Antivenom Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Monovalent Antivenom Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Monovalent Antivenom by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Monovalent Antivenom by Type (2020-2031)
 Figure 56. Global Monovalent Antivenom Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Monovalent Antivenom by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Monovalent Antivenom by Application (2020-2031)
 Figure 59. Global Monovalent Antivenom Price (US$/Unit) by Application (2020-2031)
 Figure 60. Monovalent Antivenom Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Polyvalent Antivenom Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antivenom Market Insights Forecast to 2030
Global Antivenom Serum Market Research Report 2024
Global Anti Venom Market Insights Forecast to 2030
Antivenoms for Treating Spider Bites Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antivenin Market Insights Forecast to 2030
Global Snake Antivenom Immunoglobulin Market Research Report 2024
Global Venom Antiserum Market Insights Forecast to 2030
Global Snake Venom Antiserum Market Insights Forecast to 2030
Antivenene Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tetanus Human Monoclonal Antibody Market Research Report 2024
Global Antivenom Immunoglobulin Market Research Report 2025
Global Research Grade Antibodies Market Research Report 2024
Global Immunoglobulin G Antibody Therapeutics Market Insights Forecast to 2030
Intravenous Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antibody Therapeutics and Blood Antibody Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antitoxin Serum Market Research Report 2024
Global Combination Antibody Therapy Market Research Report 2024
Global Antiserum Market Research Report 2025
Monoclonal Antibody Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions